Company Overview

Siolta Therapeutics, Inc. is a biotechnology company focused on developing novel microbiome-based therapeutics to treat various diseases. With a team of experts in microbiology and healthcare, Siolta is dedicated to advancing the understanding of the gut microbiome and its role in human health. Their innovative research and cutting-edge technology have the potential to revolutionize treatment options for conditions such as inflammatory bowel disease and allergies.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

3 Patents

#87 in San Carlos, CA

#16,858 in California

#73,860 in US

San Carlos, CA, United States of America

Siolta Therapeutics, Inc.

Forward Citations = 0

5 inventors:

Nikole Kimes (3 out of 5 patents)

Ricardo Valladares (3 out of 5 patents)

Neeraja Vajrala (2 out of 2 patents)

4. Benjamin Fiebiger (1 out of 1 patent)

5. Susan V Lynch (1 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Siolta Therapeutics, Inc.. Retrieved from https://idiyas.com/company/siolta-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]